Drug major Lupin Ltd has said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients. In a regulatory filing, the company said “the board of directors has approved the company’s entry into the digital healthcare space…”

• Glenmark Pharma Shares Gain 1% on Receiving USFDA Approval 
• Stocks Under F&O Ban: Vodafone Idea
• Stocks in Focus: Vodafone Idea, Maruti Suzuki, ICICI Bank, and Others
• Vedanta Outlook for the Week (April 29, 2024 – May 03, 2024)
• Tata Steel Outlook for the Week (April 29, 2024 – May 03, 2024)

The company said it has recently incorporated a new entity in the name of Lupin Digital Health Ltd, as a wholly-owned subsidiary, which will undertake this, the filing added. Lupin, however, did not share any other details about the new venture. Shares of Lupin Ltd were trading 0.29 per cent lower at Rs 1,243.30 apiece on BSE.

Stock Covered in the news

Lupin Ltd-View Detailed Analysis